BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 05:15 pm
Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Suraksha Diagnostic Ltd · 544293
✦ AI SummaryResults
Suraksha Diagnostic Ltd has informed BSE that a Board meeting is scheduled on 12/08/2026 to consider and approve unaudited financial results for the quarter ended 30 June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Suraksha Diagnostic Ltd - 544293 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
811e082d-a907-4de4-bbc8-ffb27b7814b0.pdf
View document text
Date: 04 August 2026
The Secretary The Secretary
BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block
Dalal Street Bandra -Kurla Complex, Bandra (East)
Mumbai - 400 001 Mumbai- 400 051
Scrip Code: 544293 Scrip Symbol : SURAKSHA
Dear Sir / Ma’am,
Sub: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be
held on Wednesday, 12 August, 2026, at the registered office of the Company, to inter-alia, consider
and approve the unaudited (standalone and consolidated) financial results of the Company for the
quarter ended 30 June 2026.
Further, in continuation to our intimation letter dated Monday, 15 June 2026, regarding closure of
trading window for the aforesaid purpose, and in accordance with the Company's Internal Code of
Conduct for Prohibition of Insider Trading, framed pursuant to the provisions of SEBI (Prohibition of
Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company
which was closed from Wednesday, 01 July 2026 for all the directors, KMP’s, designated persons,
employees, connected persons and their immediate relatives shall re-open after the expiry of 48 hours
from the date of declaration of the said financial results.
Please note that this information is also available at the website of the Company at
www.surakshanet.com.
We request you to take the above on record.
Thanking you.
For Suraksha Diagnostic Limited
Ritu Mittal
Joint Managing Director & CEO
DIN: 00165886
Suraksha Diagnostic Limited
CIN: L85110WB2005PLC102265
Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New
Town, Kolkata-700 156, West Bengal, India
E-mail: investors@surakshanet.com I Website: www.surakshanet.com
Phone:(033) 6605 9750